Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Corcept Therapeutics (CORT)

18.015 -0.215 (-1.18%)

05-22 10:11

Open:

18.24

Pre. Close:

18.23

High:

18.44

Low:

17.79

Volume:

107,000

Market Cap:

2076M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

18.995 - 19.091

19.091 - 19.153

Low:

17.846 - 17.971

17.971 - 18.05

Close:

18.051 - 18.239

18.239 - 18.359

Technical analysis  (as of: 2018-05-22 10:03:58 AM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 22.17     One year: 25.89

Support:

Support1: 16.53    Support2: 15.02

Resistance:

Resistance1: 18.98    Resistance2: 22.17

Pivot:

17.41

Moving Averages:

MA(5): 18.12     MA(20): 17.29

MA(100): 18.00     MA(250): 16.59

MACD:

MACD(12,26): 0.28     Signal(12,26,9): 0.14

%K %D:

%K(14,3): 85.91     %D(3): 90.81

RSI:

RSI(14): 56.83

52-Week:

High: 25.96  Low: 10.4  Change(%): 49.2

Average Vol(K):

3-Month: 129586  10-Days 145257

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CORT has closed below upper band by 26.0%. Bollinger Bands are 43.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to CORT's normal range. The bands have been in this narrow range for 31 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-21T03:20:33-04:00
Reader Inquiry: What's In Store For Corcept Therapeutics?

2018-05-14T11:37:23-04:00
JF's Core Biotech Buys #15: Removal Of A Key Overhang, Buying Weakness In I-O, Updates And Adding To 2 Positions

2018-05-08T22:42:05-04:00
Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q1 2018 Results - Earnings Call Transcript

2018-05-08T16:21:09-04:00
Corcept Therapeutics beats by $0.03, misses on revenue

2018-05-07T17:35:34-04:00
Notable earnings after Tuesday's close

2018-05-07T15:40:31-04:00
JF's Core Biotech Buys #14: Introducing Our Final 2 Positions & Taking Advantage Of Weakness In The I-O Space

2018-05-01T02:41:27-04:00
JF's Core Biotech Buys #13: Continued Market Headwinds And How To Respond

2018-04-24T01:42:47-04:00
JF's Core Biotech Buys #12: Updates And Introducing Our 18th Selection

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

115.24

Shares Float (M)

105.83

% Held by Insiders

8.20

% Held by Institutions

91.00

Shares Short (K)

17495

Shares Short Prior Month (K)

7640

Stock Financials

EPS

0.520

EPS Est. Current Year

0.420

EPS Est. Next Year

0.700

EPS Est. Next Quarter

0.150

Forward EPS

1.420

Book Value (p.s.)

8.440

PEG Ratio

-18.30

Profit Margin

75.13

Operating Margin

33.20

Return on Assets (ttm)

89.3

Return on Equity (ttm)

107.4

Qtrly Rev. Growth

123.8

Gross Profit (p.s.)

0.664

Sales Per Share

EBITDA (p.s.)

0.230

Qtrly Earnings Growth

2039.00

Operating Cash Flow (M)

60.94

Levered Free Cash Flow (M)

41.35

atoplab.com

Valuation

P/E

34.81

P/E Growth Ratio

-0.01

P/BV

2.14

P/S

1489759360.00

P/CF

34.23

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.